Evidence map›Paper›PMID 29973381›Full record

ArticleEMBO molecular medicine2018

P2X4 receptor controls microglia activation and favors remyelination in autoimmune encephalitis.

Alazne Zabala, Nuria Vazquez-Villoldo, Björn Rissiek, Jon Gejo, Abraham Martin, Aitor Palomino, Alberto Perez-Samartín, Krishna R Pulagam, Marco Lukowiak, Estibaliz Capetillo-Zarate and 6 more

Open access · goldAbstract read
In one paragraph

Article in EMBO molecular medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 110 papers.

0numbers the graph read from it
0cells of the map it votes in
110citing papers in PubMed
14.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

110 citing papers in PubMed, 191 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Species Differences of P2X4 Receptor Modulators.ACS pharmacology & translational science · 2025
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review

50 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 3 countries.

Alazne ZabalaAchucarro Basque Center for Neurosciences, CIBERNED and Departamento de Neurociencias, Universidad del País Vasco, Leioa, Spain.
Nuria Vazquez-VilloldoAchucarro Basque Center for Neurosciences, CIBERNED and Departamento de Neurociencias, Universidad del País Vasco, Leioa, Spain.
Björn RissiekDepartment of Neurology, University Medical Center, Hamburg, Germany.
Jon GejoAchucarro Basque Center for Neurosciences, CIBERNED and Departamento de Neurociencias, Universidad del País Vasco, Leioa, Spain.
Abraham MartinMolecular Imaging Unit, CIC biomaGUNE, San Sebastian, Spain.
Aitor PalominoAchucarro Basque Center for Neurosciences, CIBERNED and Departamento de Neurociencias, Universidad del País Vasco, Leioa, Spain.
Alberto Perez-SamartínAchucarro Basque Center for Neurosciences, CIBERNED and Departamento de Neurociencias, Universidad del País Vasco, Leioa, Spain.
Krishna R PulagamMolecular Imaging Unit, CIC biomaGUNE, San Sebastian, Spain.
Marco LukowiakDepartment of Neurology, University Medical Center, Hamburg, Germany.
Estibaliz Capetillo-ZarateAchucarro Basque Center for Neurosciences, CIBERNED and Departamento de Neurociencias, Universidad del País Vasco, Leioa, Spain.
Jordi LlopMolecular Imaging Unit, CIC biomaGUNE, San Sebastian, Spain.
Tim MagnusDepartment of Neurology, University Medical Center, Hamburg, Germany.
Friedrich Koch-NolteInstitute of Immunology, University Medical Center, Hamburg, Germany.
Francois RassendrenInstitut de Génomique Functionnelle, CNRS UMR5203, Montpellier, France.
Carlos MatuteAchucarro Basque Center for Neurosciences, CIBERNED and Departamento de Neurociencias, Universidad del País Vasco, Leioa, Spain carlos.matute@ehu.es maria.domercq@ehu.es.ORCID 0000-0001-8672-711X
María DomercqAchucarro Basque Center for Neurosciences, CIBERNED and Departamento de Neurociencias, Universidad del País Vasco, Leioa, Spain carlos.matute@ehu.es maria.domercq@ehu.es.ORCID 0000-0002-4918-9276
University of the Basque Country · ESUniversität Hamburg · DECIC biomaGUNE · ESCentre National de la Recherche Scientifique · FRIkerbasque · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microglia survey the brain microenvironment for signals of injury or infection and are essential for the initiation and resolution of pathogen- or tissue damage-induced inflammation. Understanding the mechanism of microglia responses during pathology is hence vital to promote regenerative responses. Here, we analyzed the role of purinergic receptor P2X4 (P2X4R) in microglia/macrophages during autoimmune inflammation. Blockade of P2X4R signaling exacerbated clinical signs in the experimental autoimmune encephalomyelitis (EAE) model and also favored microglia activation to a pro-inflammatory phenotype and inhibited myelin phagocytosis. Moreover, P2X4R blockade in microglia halted oligodendrocyte differentiation

Indexed as

Adenosine TriphosphateAnimalsEncephalomyelitis, Autoimmune, ExperimentalFemaleGene ExpressionInflammationIvermectinMacrophagesMiceMicrogliaMyelin SheathOligodendrogliaPhagocytosisPurinergic P2X Receptor AntagonistsRatsReceptors, Purinergic P2X42',3'-O-(2,4,6-trinitro-cyclohexadienylidine)adenosine 5'-triphosphateAdenosine TriphosphateIvermectinPurinergic P2X Receptor AntagonistsReceptors, Purinergic P2X4microgliamyelin phagocytosisP2X4 receptorremyelination

Identifiers

PMID29973381
PMCPMC6079537
OpenAlexW2809777794

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.